Menu
Recruiting NCT04579835

Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)

Observational Breech Presentation Twin; Complicating Pregnancy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: External Cephalic Version.
Who it may be relevant to
Registry conditions: Breech Presentation, Twin; Complicating Pregnancy. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Twin A Breech External Cephalic Version Intervention Trial

Overview

A prospective study assessing the use of external cephalic version for the management of Twin A breech presentation in twin pregnancy.

Detailed description

The primary goal of the study is to determine the success rate of Twin A external Cephalic Version in our obstetric clinic and to determine new favorable sonographic criteria associated with a successful attempt that have not been investigated before.

Interventions

  • Other External Cephalic Version
    External Cephalic Version Twin A

Primary outcome measures

  • Success rate of external cephalic version Twin A [Time frame: 4 hours after external cephalic version]
Secondary outcome measures (10)
  • Fetal weight [Time frame: 30 Minutes before external cephalic version]
  • Fetal Doppler Umbilical Pulsatility Index [Time frame: 30 Minutes before external cephalic version]
  • Fetal Doppler Umbilical Resistance Index [Time frame: 30 Minutes before external cephalic version]
  • Incidence of pathological cardiotocogramm [Time frame: 60 Minutes after external cephalic version]
  • Incidence of emergency delivery [Time frame: 60 Minutes after external cephalic version]
  • Incidence of bleeding [Time frame: 60 Minutes after external cephalic version]
  • Incidence of contractions [Time frame: 60 Minutes after external cephalic version]
  • Incidence of rupture of membranes [Time frame: 60 Minutes after external cephalic version]
  • Pain scores [Time frame: 60 Minutes after external cephalic version]
  • Mode of Delivery [Time frame: 6 weeks after delivery]

Eligibility criteria

Inclusion criteria

  • Presence of the written consent of the patients.
  • The patients must be over 18 years old .
  • No limit in the ability to consent.

Exclusion criteria

  • Age under 18
  • Limited ability to consent
  • Placenta previa
  • Fetal abnormalities

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Germany · 1 center
  • Charité University Hospital — Mitte

Identifiers

NCT: NCT04579835 · EA2/116/20

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗